Clinical trials
Hyperlipoproteinemia Type II trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 1 |
| 2019 | 3 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Recruiting | 6 |
| Terminated | 3 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Laval University | 5 |
| Pfizer | 4 |
| Amgen | 3 |
| Kastle Therapeutics, LLC | 3 |
| AstraZeneca | 2 |
| Cerenis Therapeutics, SA | 2 |
| Novartis Pharmaceuticals | 2 |
| REGENXBIO Inc. | 2 |
| Verve Therapeutics, Inc. | 2 |
| Aegerion Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipoproteinemia Type II | 40 |
| Hypercholesterolemia | 13 |
| Homozygous Familial Hypercholesterolemia | 11 |
| Hyperlipidemias | 6 |
| Metabolic Diseases | 6 |
| Atherosclerosis | 5 |
| Genetic Diseases, Inborn | 5 |
| Lipid Metabolism Disorders | 4 |
| Cardiovascular Diseases | 3 |
| Coronary Artery Disease | 3 |
Trials
Showing 51 to 40 of 40. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.